METHOD FOR TREATING OSTEOGENESIS IMPERFECTA TYPE V

摘要

The present application relates to methods of inhibiting the activity or expression of BRIL, and to methods of treating diseases related to expression of a mutant BRIL. In certain embodiments, the disease is osteogenesis imperfecta (OI) type V. The present application is also directed to methods of identifying compounds that inhibit the activity or expression of BRIL.